Translations:Pyridoxamine/6/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
FuzzyBot (talk | contribs)
Importing a new version from external source
 
(No difference)

Latest revision as of 14:38, 4 April 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Pyridoxamine)
Pyridoxamine also inhibits the formation of advanced lipoxidation endproducts during [[lipid peroxidation]] reactions by reaction with di[[carbonyl]] intermediates. In other preclinical research, pyridoxamine may be efficacious in treating [[diabetic neuropathy]] and [[retinopathy]] associated with diabetes and [[kidney stone]] disease. In one study, pyridoxamine was more effective at protecting from [[ionizing radiation]]-induced [[gastrointestinal]] [[epithelial]] [[apoptosis]] than [[amifostine]] (the only [[wikt:radioprotector|radioprotector]] currently [[Food and Drug Administration]] (FDA)-approved) due to pyridoxamine reactive oxygen species and reactive carbonyl species scavenging profile.

Pyridoxamine also inhibits the formation of advanced lipoxidation endproducts during lipid peroxidation reactions by reaction with dicarbonyl intermediates. In other preclinical research, pyridoxamine may be efficacious in treating diabetic neuropathy and retinopathy associated with diabetes and kidney stone disease. In one study, pyridoxamine was more effective at protecting from ionizing radiation-induced gastrointestinal epithelial apoptosis than amifostine (the only radioprotector currently Food and Drug Administration (FDA)-approved) due to pyridoxamine reactive oxygen species and reactive carbonyl species scavenging profile.